BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 23365124)

  • 1. Bromocriptine-induced brainstem angulation in a patient with invasive prolactinoma.
    Lou XH; Wu ZB; Zhang YZ
    J Clin Endocrinol Metab; 2013 Mar; 98(3):867-8. PubMed ID: 23365124
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of bromocriptine during pregnancy and appearance of partial empty sella turcica in women with prolactinoma].
    López de la Torre Casares M; Rodríguez Poyo-Guerrero P; Garrido Pérez M; Moreno Esteban B
    Rev Clin Esp; 1991 Nov; 189(7):343-4. PubMed ID: 1767093
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of empty sella syndrome with ventriculoperitoneal shunt.
    Lee TC; Yang LC; Huang PL
    J Clin Neurosci; 2005 Feb; 12(2):201-5. PubMed ID: 15749434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregnancy in a patient with prolactinoma off treatment.
    Sood A; Kalra S; Gulati MS; Mittal S
    J Assoc Physicians India; 2000 Dec; 48(12):1221. PubMed ID: 11280238
    [No Abstract]   [Full Text] [Related]  

  • 5. Amyotrophic lateral sclerosis and prolactinoma.
    Kararizou E; Stamboulis E; Markou I; Alevizaki M; Gkiatas K
    Funct Neurol; 2007; 22(1):39-41. PubMed ID: 17509242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Invasive giant prolactinoma].
    Domínguez Ugidos LJ; Martínez Subías J; Urpegui García A; Sancho Serrano E; Alfonso Collado JI; Vallés Varela H
    Acta Otorrinolaringol Esp; 1998 Mar; 49(2):156-8. PubMed ID: 9650316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endonasal endoscopic transsphenoidal chiasmapexy using a clival cranial base cranioplasty for visual loss from massive empty sella following macroprolactinoma treatment with bromocriptine: case report.
    Alvarez Berastegui GR; Raza SM; Anand VK; Schwartz TH
    J Neurosurg; 2016 Apr; 124(4):1025-31. PubMed ID: 26339851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Five years follow-up of invasive prolactinomas with special reference to the control of cavernous sinus invasion.
    Wu ZB; Su ZP; Wu JS; Zheng WM; Zhuge QC; Zhong M
    Pituitary; 2008; 11(1):63-70. PubMed ID: 17917811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative resistance of a macroprolactinoma to bromocriptine therapy during pregnancy.
    Shanis BS; Check JH
    Gynecol Endocrinol; 1996 Apr; 10(2):91-4. PubMed ID: 8701792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid re-enlargement of a macroprolactinoma after initial shrinkage in a young woman treated with bromocriptine.
    Adler I; Barsi P; Czirják S; Varga I; Gergics P; Jakab C; Rácz K
    Gynecol Endocrinol; 2005 Jun; 20(6):317-21. PubMed ID: 16019380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bromocriptine as a Potential Glucose-lowering Agent for the Treatment of Prolactinoma with Type 2 Diabetes.
    Oshige T; Nakamura Y; Sasaki Y; Kawano S; Ohki T; Tsuruta M; Tokubuchi I; Nakayama H; Yamada K; Ashida K; Tajiri Y; Nomura M
    Intern Med; 2019 Nov; 58(21):3125-3128. PubMed ID: 31243214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remission of Recurrent Cochlear Hydrops Associated With Bromocriptine Treatment for Macroprolactinoma.
    Košec A; Kruljac I; Ajduk J
    Am J Audiol; 2019 Sep; 28(3):548-552. PubMed ID: 31430172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Her vision was tied down.
    Dorotheo EU; Tang RA; Bahrani HM; Schiffman JS; Bhatti MT; Lewis SB
    Surv Ophthalmol; 2005; 50(6):588-97. PubMed ID: 16263371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transsphenoidal treatment of secondary empty sella syndrome using low field strength intraoperative MRI: case report.
    Kubben PL; Cornips EM; Looij BJ; Beuls EA
    Minim Invasive Neurosurg; 2010 Aug; 53(4):198-202. PubMed ID: 21132613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Giant prolactinoma: where's the prolactin?
    Tailor C; Teo I; Sorisky A
    Clin Neurol Neurosurg; 2011 Nov; 113(9):810-2. PubMed ID: 21906866
    [No Abstract]   [Full Text] [Related]  

  • 16. Growth of prolactinoma despite lowering of serum prolactin by bromocriptine.
    Kupersmith MJ; Kleinberg D; Warren FA; Budzilovitch G; Cooper P
    Neurosurgery; 1989 Mar; 24(3):417-23. PubMed ID: 2927618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Morphological changes in prolactinoma induced by bromocriptine treatment].
    Scanarini M
    Minerva Endocrinol; 1990; 15(1):13-5. PubMed ID: 2274009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Decreased tumor size in hypophyseal macroadenoma--empty sella syndrome].
    Tammann T
    Praxis (Bern 1994); 2001 Feb; 90(7):267-8. PubMed ID: 11256227
    [No Abstract]   [Full Text] [Related]  

  • 19. [Long-term bromocriptine treatment of giant prolactinoma: report of a case].
    Mashio Y; Beniko M; Ikota A; Mizumoto H; Sato S; Yamaguchi O; Suzuki S; Tashiro T; Ikota T
    Nihon Naika Gakkai Zasshi; 1989 Dec; 78(12):1785-6. PubMed ID: 2625603
    [No Abstract]   [Full Text] [Related]  

  • 20. Polycystic ovary syndrome and prolactinoma association.
    Yavasoglu I; Kucuk M; Coskun A; Guney E; Kadikoylu G; Bolaman Z
    Intern Med; 2009; 48(8):611-3. PubMed ID: 19367058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.